MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ADVM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Adverum Biotechnologies (ADVM) Ownership - Who owns Adverum Biotechnologies?

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
96.26M
P/E Ratio
N/A
Total Cash
26.06M
Projected Growth
N/A
Total Debt
88.94M
Revenue
N/A
Risk (Beta)
1.96
Dividend Yield
N/A
Total Cash/Share
1.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ADVM
A.I. Advisor
published General Information

General Information

a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com